questionText: To ask the Secretary of State for Health and Social Care, with reference to the National Patient Safety Alert entitled Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets,
answerText: We are aware of supply issues affecting medicines used for the management of attention deficit hyperactivity disorder (ADHD). We have issued communications, in the form of a National Patient Safety Alert, to the National Health Service to advise healthcar...
heading: Drugs: Shortages